Oxyphencyclimine Hydrochloride

CHEMBL1200891 Phase 4 Disetujui Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

380.9 g/mol

LogP

—

Phase

4

A hydrochloride salt form of oxyphencyclimine, sharing the same therapeutic uses.

Berat Molekul

380,9000 g/mol

TPSA

62,10 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CN1CCCN=C1COC(=O)C(O)(c1ccccc1)C1CCCCC1.Cl

InChI

InChI=1S/C20H28N2O3.ClH/c1-22-14-8-13-21-18(22)15-25-19(23)20(24,16-9-4-2-5-10-16)17-11-6-3-7-12-17;/h2,4-5,9-10,17,24H,3,6-8,11-15H2,1H3;1H

Molecular Formula

C20H29ClN2O3

HBD / HBA

2 / 4

Ikatan yang Dapat Dirotasi

6

Atom Berat

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

A hydrochloride salt form of oxyphencyclimine, sharing the same therapeutic uses.

Yes, Oxyphencyclimine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200891. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 66061. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Mencari informasi yang ramah bagi pasien?

Oxyphencyclimine Hydrochloride di PillFYI

Struktur

Data Cepat

Rumus: C20H29ClN2O3

Tautan Eksternal

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.